![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A01N 43/16 | |
A61K 31/35 | |||
A61P 35/00 |
(11) | Number of the document | 2547334 |
(13) | Kind of document | T |
(96) | European patent application number | 11757134.9 |
Date of filing the European patent application | 2011-03-21 | |
(97) | Date of publication of the European application | 2013-01-23 |
(45) | Date of publication and mention of the grant of the patent | 2017-11-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/029281 |
Date | 2011-03-21 |
(87) | Number | WO 2011/116398 |
Date | 2011-09-22 |
(30) | Number | Date | Country code |
315890 P | 2010-03-19 | US | |
325814 P | 2010-04-19 | US | |
315886 P | 2010-03-19 | US |
(72) |
LI, Chiang, Jia, US
LEGGETT, David, US
LI, Youzhi, US
LI, Wei, US
|
(73) |
1Globe Biomedical Co., Ltd.,
8F, Block B, Techart Plaza, No.30 Xueyuan Road, Haidan District, Beijing 100083,
CN
|
(54) | NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS |
NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS |